Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Celltrion Wins Global First Approval For High-Concentration Humira Biosimilar
Yuflyma 100mg/ml Version Of Adalimumab Ready For Launch In Europe
Feb 15 2021
•
By
David Wallace
Celltrion has the first higher-strength adalimumab biosimilar • Source: Shutterstock
More from Biosimilars
More from Products